Filing Details
- Accession Number:
- 0000950170-23-039299
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-08-07 21:39:25
- Reporting Period:
- 2023-08-03
- Accepted Time:
- 2023-08-07 21:39:25
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1661998 | Homology Medicines Inc. | FIXX | Pharmaceutical Preparations (2834) | 473468154 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1968554 | Julie Jordan | C/O Homology Medicines, Inc. One Patriots Park Bedford MA 01730 | Chief Medical Officer | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2023-08-03 | 1,548 | $0.00 | 4,318 | No | 4 | M | Direct | |
Common Stock | Disposition | 2023-08-03 | 436 | $1.39 | 3,882 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2023-08-03 | 387 | $0.00 | 4,269 | No | 4 | M | Direct | |
Common Stock | Disposition | 2023-08-03 | 109 | $1.39 | 4,160 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2023-08-03 | 4,644 | $0.00 | 8,804 | No | 4 | M | Direct | |
Common Stock | Disposition | 2023-08-03 | 1,308 | $1.39 | 7,496 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Restricted Stock Units | Disposition | 2023-08-03 | 1,548 | $0.00 | 1,548 | $0.00 |
Common Stock | Restricted Stock Units | Disposition | 2023-08-03 | 387 | $0.00 | 387 | $0.00 |
Common Stock | Restricted Stock Units | Disposition | 2023-08-03 | 4,644 | $0.00 | 4,644 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | No | 4 | M | Direct | ||
0 | No | 4 | M | Direct | ||
0 | No | 4 | M | Direct |
Footnotes
- Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. The restricted stock units have no expiration date.
- The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 instruction entered into on May 27, 2022 solely with the intent to cover taxes in connection with the vesting of certain previously reported restricted stock units.
- The sales reported in the Form 4 were effected pursuant to a mandatory sell to cover arrangement solely with the intent to cover taxes in connection with the vesting of certain previously reported restricted stock units.
- Vesting for a portion of the restricted stock units was accelerated and such portion vested and settled on August 3, 2023. The restricted stock units would otherwise have vested and settled as to one half of the restricted stock units on each of January 1, 2024 and January 1, 2025. The remaining restricted stock units have been automatically cancelled and forfeited.
- Vesting for a portion of the restricted stock units was accelerated and such portion vested and settled on August 3, 2023. The restricted stock units would otherwise have vested and settled as to one third of the restricted stock units on each of the first three anniversaries of January 1, 2023 so that such restricted stock units would have become fully vested on January 1, 2026. The remaining restricted stock units have been automatically cancelled and forfeited.